Publications | Lund University Publications

1 – 3 of 3

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Nahi%2C+H.%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Nahi%2C+H.%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2017
Mark Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors : a multicenter IMWG study
Dimopoulos, M. A. ; Kastritis, E ; Terpos, E ; Nahi, H ; Goldschmidt, H. ; Hillengass, J ; Leleu, X ; Beksac, Meral ; Alsina, M and Oriol, Albert , et al. (2017) In Leukemia 31. p.2443-2448
- Contribution to journal › Article
2016
Mark Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994-2009
Rosengren, S. ; Mellqvist, U. H. ; Nahi, H. ; Forsberg, K. ; Lenhoff, S. ^LU ; Strömberg, O. ; Ahlberg, L. ; Linder, O. and Carlson, K. (2016) In Bone Marrow Transplantation 51(12). p.1569-1572
- Contribution to journal › Article
2008
Mark The FLT3 inhibitor PKC412 in combination with cytostatic drugs in vitro in acute myeloid leukemia
Mollgard, L ; Deneberg, S ; Nahi, H ; Bengtzen, S ; Jonsson-Videsater, K ; Fioretos, Thoas ^LU ; Andersson, Anna ^LU ; Paul, C and Lehmann, S (2008) In Cancer Chemotherapy and Pharmacology 62(3). p.439-448
- Contribution to journal › Article